Alkaloids derived from Amaryllidaceae species have shown acetylcholinesterase (AChE) inhibitory activity, making them potential candidates for Alzheimer’s disease treatment (Marucci et al., 2021). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.